TECH(Bio-Techne Corporation) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-06-30 | FY 截至 2023-06-30 | FY 截至 2024-06-30 | FY 截至 2025-06-30 | FY 截至 2026-06-30 |
|---|---|---|---|---|---|
| 营业收入 | $1.11B | $1.14B | $1.16B | $1.22B | $1.22B |
| 毛利润 | $756.50M | $769.82M | $769.73M | $790.27M | $799.07M |
| 营业利润 | $296.59M | $298.94M | $206.69M | $102.25M | $251.89M |
| 净利润 | $272.05M | $285.26M | $168.10M | $73.40M | $181.86M |
| 经营现金流 | $325.27M | $254.39M | $298.98M | $287.56M | $292.07M |
| 自由现金流 | $280.36M | $216.15M | $236.10M | $256.55M | $263.22M |
| 摊薄每股收益 | $1.66 | $1.76 | $1.05 | $0.46 | $1.16 |